Jefferson Health

Physician Profile

Adam Dicker, MD, PhD, FASTRO

Jefferson University Physician

Academic Title: Professor
Sr. VP and Chair, Enterprise Radiation Oncology
Professor of Radiation Oncology, Pharmacology & Experimental Therapeutics

Specialties
Radiation Oncology
Radiation Oncology - Bladder Cancer
Radiation Oncology - Brain Tumor
Radiation Oncology - Kidney Cancer
Radiation Oncology - Prostate Cancer
Radiation Oncology - Testicular Cancer

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
Bodine Center, Suite G-301
111 South 11th Street
Philadelphia PA 19107
Phone: (215) 955-6702
Fax: (215) 955-0412

Medical Services

Years in Practice

21

Board Certifications

  • Radiation Oncology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Awards and Honors

Philadelphia Magazine's Top Docs 2016,2015,2014,2013,2012,2011,2010

Personal Statement

I provide personalized medicine using the latest developments in individualized genomic health. Each patient is treated as a family member.

Education

  • Cornell University Medical College, Medical School

Internship

  • Lenox Hill Hospital, NY

Residency

  • Memorial Sloan-Kettering Cancer Center, NY

Fellowship

  • Memorial Sloan-Kettering Cancer Center, NY

Recent Publications

RB loss promotes prostate cancer metastasis

Reaffirming and clarifying the American Society of Clinical Oncology's policy statement on the critical role of phase i trials in cancer research and treatment

Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential

Patient-level DNA damage and repair pathway profiles and prognosis after prostatectomy for high-risk prostate cancer

Closed loop control of a robot assisted smart flexible needle for percutaneous intervention

Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer

Reply to C.G. Rusthoven et al

Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data

Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis

Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy

Radiation therapy after radical prostatectomy for prostate cancer: Evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort

Novel actions of next-generation taxanes benefit advanced stages of prostate cancer

African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men

American society of clinical oncology policy statement update: The critical role of phase I trials in cancer research and treatment

Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: Evaluation of outcomes in the regione Emilia-Romagna, Italy

Current Clinical Trials Testing Combinations of Immunotherapy and Radiation

African-American race is a predictor of seminal vesicle invasion after radical prostatectomy

African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men

Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: Comparative analysis of long-term outcomes

Quantifying unnecessary normal tissue complication risks due to suboptimal planning: A secondary study of RTOG 0126